Followers | 16 |
Posts | 1244 |
Boards Moderated | 0 |
Alias Born | 03/15/2016 |
Tuesday, March 31, 2020 8:45:17 AM
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its newly developed QIAstat-Dx Respiratory SARS-CoV-2 Panel test for use in diagnosing patients infected with the novel COVID-19 coronavirus.
QGEN Full PR
Recent QGEN News
- Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer • GlobeNewswire Inc. • 10/07/2024 08:05:00 PM
- QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology • GlobeNewswire Inc. • 09/30/2024 08:05:00 PM
- QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays • GlobeNewswire Inc. • 09/26/2024 08:05:00 PM
- PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples • GlobeNewswire Inc. • 09/25/2024 08:05:00 PM
- QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database • GlobeNewswire Inc. • 09/23/2024 08:05:00 PM
- QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform • GlobeNewswire Inc. • 09/18/2024 08:05:00 PM
- QIAGEN and Bio-Manguinhos/Fiocruz collaborate to enhance malaria and dengue detection in Brazil’s national screening programs • GlobeNewswire Inc. • 09/12/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2024 10:18:49 PM
- QIAGEN and Lilly collaborate to support development of a QIAstat-Dx IVD panel that identifies patients at risk for developing Alzheimer’s disease • GlobeNewswire Inc. • 09/04/2024 08:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/03/2024 08:16:40 PM
- QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases • GlobeNewswire Inc. • 08/28/2024 08:05:00 PM
- Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12% • GlobeNewswire Inc. • 08/06/2024 08:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/02/2024 01:24:48 AM
- QIAGEN delivers solid performance and exceeds outlook for Q2 2024 • GlobeNewswire Inc. • 07/31/2024 08:06:25 PM
- QIAGEN to enhance the identification of human remains of Indigenous people and African Americans • GlobeNewswire Inc. • 07/08/2024 08:05:00 PM
- QIAGEN N.V. to release results for Q2 2024 and hold webcast • GlobeNewswire Inc. • 07/02/2024 01:29:56 PM
- QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children • GlobeNewswire Inc. • 06/27/2024 08:05:00 PM
- QIAGEN announces 2028 strategy for solid profitable growth • GlobeNewswire Inc. • 06/17/2024 11:30:00 AM
- QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs • GlobeNewswire Inc. • 06/13/2024 08:05:00 PM
- QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth • GlobeNewswire Inc. • 06/12/2024 08:05:00 PM
- QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance • GlobeNewswire Inc. • 06/11/2024 08:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/06/2024 08:50:44 PM
- QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period • GlobeNewswire Inc. • 06/06/2024 08:05:00 PM
- QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe • GlobeNewswire Inc. • 06/05/2024 08:05:00 PM
- QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care • GlobeNewswire Inc. • 06/03/2024 06:00:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM